Detalhes do Documento

Genetic studies in a cluster of Mucopolysaccharidosis Type VI patients in Northeast Brazil


Descrição

Texto completo: acesso restrito. p. 603–607

Submitted by Edileide Reis (leyde-landy@hotmail.com) on 2014-02-18T14:15:01Z No. of bitstreams: 1 Angelina Xavier Acosta.pdf: 573475 bytes, checksum: ff2398be5885fcbb0b5cb9b8d18b74be (MD5)

Approved for entry into archive by Flávia Ferreira (flaviaccf@yahoo.com.br) on 2014-11-28T15:51:33Z (GMT) No. of bitstreams: 1 Angelina Xavier Acosta.pdf: 573475 bytes, checksum: ff2398be5885fcbb0b5cb9b8d18b74be (MD5)

Made available in DSpace on 2014-11-28T15:51:33Z (GMT). No. of bitstreams: 1 Angelina Xavier Acosta.pdf: 573475 bytes, checksum: ff2398be5885fcbb0b5cb9b8d18b74be (MD5) Previous issue date: 2011

Mucopolysaccharidosis type VI (MPS VI, Maroteaux–Lamy syndrome) is a lysosomal storage disease caused by deficiency of arylsulphatase B. The incidence of MPS VI is very low, usually less than 1 case for every 1,000,000 newborns. In Northeast Brazil we identified in the county of Monte Santo (52,360 inhabitants) thirteen patients with MPS VI. The aim of this work was to identify the mutation(s) present in these patients and analyze intragenic SNPs to define possible haplotypes. The 13 MPS VI patients were found to be homozygous for the p.H178L mutation. All patients have the same haplotype for the intragenic SNPs. Based on current data, the prevalence of MPS VI in this region is estimated as 1:5,000 newborns. These results, together with pedigree analysis, strongly suggest a founder effect accounting for the high frequency of p.H178L mutation in this area. This reinforces the need of a comprehensive community genetics program for this area.

Tipo de Documento Artigo científico
Idioma Inglês
facebook logo  linkedin logo  twitter logo 
mendeley logo

Documentos Relacionados

Não existem documentos relacionados.